Connecticut United for Research Excellence (CURE) said it’s hopeful for more international collaboration now that it’s welcomed its first Chinese member company.
HLK Biotechnogy Co. Ltd. is the life and health care sciences network’s newest member.
Susan Froshauer, president and CEO of CURE, said the group aims to help HLK expand its business in the United States and also to build a U.S. China portal for bioscience firms in Connecticut.
HLK is run by Jun Xu and her business partner, Dr. Zeren Wang. Both acquired U.S. citizenship and have homes in Connecticut, but spend approximately 80 percent of their time in China.
“Our goal is to bridge the West and the East in order to bring efficacious and safe medicines to patients in both countries,” Xu said in a statement. “After two years in China, we know how to navigate the hurdles of doing business in that country, with regard to working with government agencies and regulators.”
Read more
Froshauer’s entrepreneurial spirit leads CT’s bioscience industry
